myirislogo
21 December, 2014 08:47 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 304.25 0.73
Hindalco In 157.65 2.64
Infosys 2001.90 1.81
Icici Bank 355.40 2.95
Tata Stl 405.20 2.99
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Jenburkt Pharmaceuticals Limited
Jenburkt Pharmaceuticals Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524731NSE:NABloomberg:JBP@INReuters:JENA.BO
Market Lot: 1Face Value: 10ISIN Demat: INE354A01013
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
16-JUL-13 Jenburkt Pharmaceuticals announced on Monday that the board has appointed Ashish U. Bhuta as chairman and managing director with effect from July 16, 2013 to Mar. 31, 2016. He was serving as the whole time director. Future Plans Jenburkt has an ambitious plan with regard to exports, especially to African countries. The company is developing new formulations as per the requirements of the importing counties. Also, product registrat...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Jenburkt Pharma board appoints directors  -IRIS 16-Jul-13
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Jun-2014(3)31-Mar-2014 (12)31-Mar-2013 (12)
Net sales 192.09762.00692.70
Other Income0.6316.1211.20
Total Income192.72778.12703.90
Cost of goods sold167.13647.10592.32
OPBDIT25.59131.02111.58
PAT14.8875.0662.15
Gross Block---
Equity capital46.4946.4946.49
EPS (Rs.)-16.5113.37
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-3.88 - 6.294.41 - 6.19
Debt / Equity (x)---
Operating margin (% of OI)13.316.815.9
Net margin (% of OI) 7.7 9.6 8.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Nirmala Apartments
93, Jayprakash Road
Andheri (West)
Mumbai
Maharashtra-400 058
PHONE
(022) 6694 3121
FAX
(022) 6694 3127
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer